Cargando…

Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed

Detalles Bibliográficos
Autores principales:	Zhang, Nasha, Kong, Li, Shi, Fang, Jing, Wang, Wang, Haiyong, Yang, Ming, Yu, Jinming, Zhu, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746418/ https://www.ncbi.nlm.nih.gov/pubmed/29300397 http://dx.doi.org/10.18632/oncotarget.23291

Ejemplares similares

Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed
por: Nasha, Zhang, et al.
Publicado: (2017)

Efficacy of cisplatin/pemetrexed with bevacizumab to treat advanced lung adenocarcinoma with different drive genes: case report and literature review
por: Wang, Haiyong, et al.
Publicado: (2016)

Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer
por: YOKOI, TAKASHI, et al.
Publicado: (2014)

Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer
por: Prager, Gerald W, et al.
Publicado: (2014)

Efficacy of Bevacizumab Combined with Pemetrexed in the Treatment of Recurrent and Metastatic Cervical Cancer
por: He, Ying, et al.
Publicado: (2022)

Carcinoembryonic Antigen in Whole Serum
por: MacSween, J. M., et al.
Publicado: (1972)

Greater efficacy of intracavitary infusion of bevacizumab compared to traditional local treatments for patients with malignant cavity serous effusion
por: Chen, Dawei, et al.
Publicado: (2016)

Pemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer: Outcomes according to Thymidylate Synthase Expression
por: Cardona, Andrés Felipe, et al.
Publicado: (2016)

Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study
por: Nakano, Takashi, et al.
Publicado: (2020)

Better efficacy of intrapleural infusion of bevacizumab with pemetrexed for malignant pleural effusion mediated from nonsquamous non-small cell lung cancer
por: Song, Xinyu, et al.
Publicado: (2018)

Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study
por: Tsutani, Yasuhiro, et al.
Publicado: (2018)

The contribution of serum enzymes and carcinoembryonic antigen to the early diagnosis of metastatic colorectal cancer.
por: Cooper, E. H., et al.
Publicado: (1975)

Clinical implication of tissue carcinoembryonic antigen expression in association with serum carcinoembryonic antigen in colorectal cancer
por: Aldilaijan, Abdulmohsin Fawzi, et al.
Publicado: (2023)

Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non‐squamous, non‐small cell lung cancer: TORG (thoracic oncology research group) 1321
por: Kasai, Takashi, et al.
Publicado: (2023)

Proceedings: Use of the carcinoembryonic antigen and serum enzyme changes in the detection of metastatic involvement of the liver.
por: Steele, L., et al.
Publicado: (1974)

Significance of serum carcinoembryonic antigen in metastatic breast cancer patients: A prospective study
por: Anoop, Thattungal Manoharan, et al.
Publicado: (2022)

The Significance of Serum Carcinoembryonic Antigen in Lung Adenocarcinoma
por: Kim, Jae Jun, et al.
Publicado: (2015)

On-Site Detection of Carcinoembryonic Antigen in Human Serum
por: Mahmoudi, Tohid, et al.
Publicado: (2021)

PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer
por: Zinner, Ralph G., et al.
Publicado: (2015)

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma
por: Ceresoli, G L, et al.
Publicado: (2013)

Carcinoembryonic Antigen Level Can be Overestimated in Metabolic Syndrome
por: Kim, Kyu-Nam, et al.
Publicado: (2011)

Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma
por: Lin, Zhong, et al.
Publicado: (2017)

Bevacizumab in Combination with Pemetrexed and Platinum Significantly Improved the Clinical Outcome of Patients with Advanced Adenocarcinoma NSCLC and Brain Metastases
por: Tian, Yaru, et al.
Publicado: (2019)

Serum Carcinoembryonic Antigen for Recurrence in Colorectal Cancer Patients
por: Kim, Young Jin
Publicado: (2013)

Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer
por: Latteri, Saverio, et al.
Publicado: (2018)

Serum carcinoembryonic antigen elevation in benign lung diseases
por: Yang, Yi, et al.
Publicado: (2021)

Carcinoembryonic Antigen and Smoking
por: Clarke, Cyril, et al.
Publicado: (1980)

Carcinoembryonic Antigen and Smoking
por: Clarke, C. A., et al.
Publicado: (1982)

65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer
por: Schuette, Wolfgang, et al.
Publicado: (2017)

Efficacy and safety of first-line pemetrexed plus carboplatin followed by single-agent pemetrexed maintenance in elderly Chinese patients with non-squamous non-small-cell lung cancer
por: Zhao, Xinmin, et al.
Publicado: (2017)

Diagnostic value of carcinoembryonic antigen combined with cytokines in serum of patients with colorectal cancer
por: Ma, Yunfeng, et al.
Publicado: (2022)

Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland
por: Barbier, Michaela Carla, et al.
Publicado: (2023)

MTAP-deficiency could predict better treatment response in advanced lung adenocarcinoma patients initially treated with pemetrexed-platinum chemotherapy and bevacizumab
por: Jing, Wang, et al.
Publicado: (2020)

Carcinoembryonic antigen (CEA) "fingerprints".
por: Rule, A. H., et al.
Publicado: (1973)

Carcinoembryonic antigen in hepatocellular cancer.
por: Macnab, G. M., et al.
Publicado: (1978)

Limits of serum carcinoembryonic antigen and carbohydrate antigen 19-9 as the diagnosis of gallbladder cancer
por: Kang, Jae Seung, et al.
Publicado: (2021)

A Carcinoembryonic Antigen-Secreting Adenocarcinoma Arising in Tailgut Cyst : Clinical Implications of Carcinoembryonic Antigen
por: Cho, Byoung Chul, et al.
Publicado: (2005)

Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma
por: Zhang, Bin, et al.
Publicado: (2016)

Factors Associated with Serum Levels of Carcinoembryonic Antigen in Healthy Non-smokers
por: No, Jung-Im, et al.
Publicado: (2013)

Validation of Assaying Carcinoembryonic Antigen in Human Serum by Using Immunomagnetic Reduction
por: Wei, Po-Li, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fk8vap6mr9345psjccvrp1djsc